Volume 1, Issue 2 , Pages 97-109, December 2008
Proteomic Analysis for Tissues and Liquid from Bonghan Ducts on Rabbit Intestinal Surfaces
Article Outline
- Abstract
- 1.. Introduction
- 2.. Materials and Methods
- 3.. Results
- 4.. Discussion
- Acknowledgments
- Tables of Data
- References
- Copyright
Abstract
Research on the Bonghan system has recently prompted great interest in the theory proposed by Bong Han Kimin in the early 1960s. In order to study the biochemical characteristics of the Bonghan system, we analyzed Bonghan ducts (BHD) on the surface of rabbit intestines and characterized the liquid in the BHD at the level of the proteome. Proteomic analysis was performed using nano LC-ESI MS/MS. Using a solution digestion technique, we identified 70 different proteins in the liquid of the BHD. We used gel-based digestion to analyze the BHD itself and our results showed the presence of 207 proteins. We used these proteins to analyze gene ontology (GO) to yield insights into biological processes, molecular functions and cellular compartmentalization. Remarkably, GO clustering showed high concentrations of proteins involved in metabolism. These proteins are not usually found in blood, lymph or blood vessels, and thus can be useful for characterizing BHD. It is worth studying their association with stem cells, especially mesenchymal stem cells, cancer cells and myeloid cells.
Key words: cancer , mass spectrometry , proteomics , stem cell
1. Introduction
In the early 1960s, Bonghan Kim claimed to have discovered the anatomical structure corresponding to acupuncture meridians [1, 2]. Despite the potential significance in both Western and Eastern medicines, his work has been ignored for many years due to the absence of verification from other researchers. Only one Japanese anatomist, Fujiwara, has ever managed to replicate his results [3].
With modern fluorescence and microscopy technologies, it has become possible to rediscover the Bonghan system and this has led to a number of new research efforts. Scientists have explored the intravascular Bonghan duct (BHD) and Bonghan corpuscles (BHC) in blood vessels [4, 5, 6] and lymphatic vessels [7, 8, 9], and organ-surface BHD and BHC [10, 11]. A series of investigations to elucidate the details of BHC and BHD anatomy and morphology have been performed using confocal laser scanning microscopy [12], various electron microscopy techniques [13], x-ray microtomography [14], and immunohistochemical techniques [15]. Measurement of the flow speed of Bonghan liquid in BHD was performed by injecting Alcian Blue and the speed of travel was found to be 0.3±0.1 mm/sec [16]. Researchers also confirmed that BHC has chromaffin cells that produce and store catecholamine, suggesting a medical significance of the BHD as a hormonal pathway [17].
Our work describes an initial step towards functionally characterizing the Bonghan system in the rabbit using proteomic analysis. In order to identify BHC proteins, we used electrospray ionization (ESI) that featured a linear ion-trap mass spectrometer coupled with nano liquid chromatography (LC). The proteins identified were clustered using GO according to their involvement in biological processes, molecular function and cellular compartmentalization. Our proteomic analysis of Bonghan liquid and BHD showed remarkably high levels in carbohydrate metabolic derivatives. We compared the chemical composition of Bonghan liquid with that observed in blood [18], lymph [19] or blood vessels [20], but found similarity in composition to that more usually associated with stem cells [21, 22], cancer cells [23] and differentiated myeloid cells [24]. In particular, we identified several proteins more normally associated with mesenchymal stem cells [25, 26, 27].
2. Materials and Methods
2.1. Sample preparation
New Zealand white rabbits weighing about 1.8 kg were used for this study. The animals were housed in a temperature-controlled environment (23°C) with 60% relative humidity and a 12 hour light/dark cycle. The animals had free access to food and water and were fasted overnight before abdominal dissection. All procedures were conducted in accordance with institutional research animal care and use guidelines. The rabbits were anesthetized with intraperitoneal urethane (1.5 g/kg) and all surgical procedures were performed under general anesthesia.
We searched for BHDs on organ surfaces with the help of a stereoscopic microscope (SZX12, Olympus, Japan). The liquid in each BHD was extracted using a capillary needle and the remaining BHDs were subsequently isolated for proteomic analysis.
2.2. Tryptic digestion and LC-MS/MS analysis
The isolated BHDs were homogenized and sonicated. Then, 10 μg of tissue was loaded onto a 4–12% gradient Tris-Glycine Gel (Invitrogen, Carlsbad, CA). The PAGE-gel of the BHDs was manually segmented into 10 pieces. In-gel digestion of the gel pieces was carried out using 10 ng/μL sequencing grade modified trypsin (Promega, Madison, WI) in 50 μL of 50 mM NH4HCO4 buffer (pH 8.0) at 37°C overnight as described in the literature [28]. The liquid from the BHDs was in-sol digested directly under the same conditions as described above. The tryptic peptides were then loaded onto a fused silica microcapillary C18 column (75 μm × 10 cm).
LC separation was conducted under a linear gradient as follows: 0 min, 3% B; 5 min, 3% B; 75 min, 40% B; 80 min, 90% B; 90 min, 90% B; 91 min, 3% B; 110 min, 3% B. The initial solvent condition was 3% solvent B and the flow rate was 200 nL/min. Solvent A was 0.1% formic acid in H2O and solvent B was 0.1% formic acid in acetonitrile. The separated peptides were subsequently analyzed using a linear ion-trap mass spectrometer, LTQ (ThermoFinnigan, San Jose, CA). The electrospray voltage was set at 2.0 kV, and the threshold for switching from MS to MS/MS was 250. Each full MS scan was followed by three MS/MS scans that focused on the three most pronounced peaks of the full MS scan.
3. Results
Figure 1 shows a stereomicroscopic image of the BHD on the surface of a rabbit intestine from which the Bonghan liquid (BHL) had previously been extracted with a capillary needle.

Figure 1.
A glass capillary was inserted into a Bonghan duct, held by microforceps, above the large intestine of rabbit using in situ and in vivo stereomicroscopy (SZX12, Olympus, Japan). The capillary tip (dotted circle) was correctly inserted into the Bonghan duct in order to extract its liquid. The scale bar, located in the bottom right, is 5 mm.
3.1. Proteomic analysis of the Bonghan liquid
We investigated the BHL using ESI-MS/MS coupled with nano LC. The acquired MS/MS spectra were searched using SEQUEST's rabbit database, which listed 7490 proteins. Proteomic analysis of BHL identified 70 proteins (Table 1) and the criteria of the SEQUEST search were as mentioned in the Materials and Methods section.
Table 1. Protein list identified in Bonghan liquid
| Accession | Name | Score | MW | Peptide |
|---|---|---|---|---|
| 44889024 | Serum albumin precursor | 340.4 | 68,865 | 194 |
| 6175087 | Serotransferrin precursor | 230.3 | 76,621 | 33 |
| 112876 | Alpha-1-antiproteinase F precursor | 100.3 | 45,839 | 11 |
| 122676 | Hemoglobin subunit beta-1/2 | 90.3 | 16,122 | 32 |
| 125307 | Creatine kinase M-type | 80.3 | 43,085 | 10 |
| 113996 | Apolipoprotein A-I precursor | 80.3 | 30,573 | 10 |
| 2494026 | Histidine-rich glycoprotein precursor | 80.2 | 58,840 | 9 |
| 122475 | Hemoglobin subunit alpha-1/2 | 40.3 | 15,579 | 8 |
| 12644357 | Alpha-2-HS-glycoprotein precursor | 40.2 | 38,363 | 7 |
| 136066 | Triosephosphate isomerase (TIM) | 40.2 | 26,609 | 4 |
| 6093713 | Glycogen phosphorylase, muscle form | 40.2 | 97,228 | 4 |
| 136466 | Transthyretin (prealbumin) | 40.2 | 13,649 | 4 |
| 113608 | Fructose-bisphosphate aldolase A | 40.2 | 39,318 | 7 |
| 2851533 | Pyruvate kinase isozymes M1/M2 | 40.2 | 58,011 | 4 |
| 121088 | Ig gamma chain C region | 30.2 | 35,382 | 6 |
| 1722804 | Vitamin D-binding protein precursor | 30.2 | 52,877 | 4 |
| 20141354 | Beta-enolase | 30.2 | 47,039 | 3 |
| 116596 | Complement C3 alpha chain | 30.2 | 81,792 | 3 |
| 62287932 | Actin, alpha skeletal muscle | 20.2 | 42,024 | 3 |
| 1169794 | Glyceraldehyde-3-phosphate dehydrogenase | 20.2 | 35,799 | 2 |
| 130488651 | Serpin peptidase inhibitor, clade F | 20.2 | 54,685 | 2 |
| 130498817 | Inter-α-trypsin inhibitor heavy chain2 | 20.2 | 1,06,174 | 2 |
| 139654 | Vitronectin precursor | 20.1 | 53,909 | 2 |
| 126050 | L-lactate dehydrogenase A chain | 20.1 | 36,541 | 2 |
| 125138 | Ig kappa-b4 chain C region | 10.3 | 11,036 | 2 |
| 229506 | 750308A aldolase C | 10.3 | 38,993 | 2 |
| 21542114 | Lumican | 10.2 | 21,820 | 2 |
| 122766 | Hemoglobin subunit gamma | 10.2 | 16,214 | 7 |
| 89242507 | Ig gamma1 constant region | 10.2 | 35,334 | 2 |
| 120095 | Fibrinogen alpha chain | 10.2 | 1650 | 1 |
| 1708184 | Hemopexin precursor | 10.2 | 51,735 | 1 |
| 118600944 | Parvalbumin alpha | 10.2 | 12,057 | 1 |
| 126723362 | ATS-22 | 10.2 | 50,511 | 1 |
| 51703336 | Ubiquitin | 10.2 | 8560 | 1 |
| 552374 | Alpha-globin protein | 10.2 | 2868 | 1 |
| 130676 | Serum paraoxonase/arylesterase 1 | 10.2 | 39,984 | 1 |
| 109259 | Ig alpha chain C region (fragment) | 10.2 | 35,909 | 1 |
| 2851405 | Myosin light chain kinase, smooth muscle | 10.1 | 1,25,641 | 1 |
| 1710096 | Plasma retinol-binding protein precursor | 10.1 | 23,087 | 1 |
| 549158 | UDP-glucuronosyltransferase 2B13 precursor | 10.1 | 60,512 | 1 |
| 20178272 | Tropomyosin beta chain | 10.1 | 32,817 | 1 |
| 126722957 | Alpha-1-antiproteinase S-1 precursor | 10.1 | 45,721 | 1 |
| 130483559 | Farnesoid X activated receptor | 10.1 | 55,327 | 1 |
| 30315907 | Eukaryotic translation initiation factor 4 gamma 2 | 10.1 | 1,02,255 | 1 |
| 9910666 | Clusterin precursor (Apolipoprotein J) | 10.1 | 51,818 | 1 |
| 130502756 | Ryanodine receptor | 10.1 | 5,51,575 | 3 |
| 125295 | Creatine kinase B-type | 10.1 | 42,636 | 1 |
| 3789966 | Fibrinogen A-alpha chain | 10.1 | 41,212 | 1 |
| 125128 | 6-phosphofructokinase, muscle type | 10.1 | 85,149 | 1 |
| 126723185 | Soluble adenylyl cyclase | 10.1 | 1,85,398 | 1 |
| 127805 | Sodium/glucose cotransporter 1 | 10.1 | 73,031 | 1 |
| 1703316 | Annexin A1 (Annexin I) (Lipocortin I) | 10.1 | 38,711 | 1 |
| 126722591 | Caldesmon 1 | 10.1 | 61,445 | 1 |
| 30315951 | Probable phospholipid-transporting ATPase IF | 10.1 | 1,33,364 | 1 |
| 5739088 | Hensin | 10.1 | 29,780 | 1 |
| 75052894 | LIM and SH3 domain protein 1 | 10.1 | 29,916 | 1 |
| 1168847 | T-cell surface glycoprotein CD4 precursor | 10.1 | 50,854 | 1 |
| 26006805 | Potassium voltage-gated channel subfamily H member 2 | 10.1 | 1,26,882 | 1 |
| 126723568 | ACAP2 protein | 10.1 | 87,846 | 1 |
| 547983 | Myosin heavy chain, embryonic smooth muscle isoform | 10.1 | 58,084 | 1 |
| 47605964 | Rho-associated protein kinase 1 | 10.1 | 1,58,247 | 1 |
| 232178 | Serine hydroxymethyltransferase, cytosolic | 10.1 | 52,942 | 1 |
| 1384097 | Macrophage migration inhibitory factor-related protein-8 | 10.1 | 8376 | 1 |
| 55976305 | Sodium channel protein type 9 subunit alpha | 10.1 | 2,25,603 | 1 |
| 17366976 | Glucose-6-phosphate isomerase (GPI) | 10.1 | 62,707 | 1 |
| 50402101 | Eukaryotic peptide chain release factor subunit 1 | 10.1 | 49,000 | 1 |
| 115055 | Bleomycin hydrolase (BLM hydrolase) | 10.1 | 32,558 | 1 |
| 27373403 | Antibody variable domain | 10.1 | 12,674 | 1 |
| 123255522 | betaB2-crystallin | 10.1 | 23,389 | 1 |
| 125987 | Lipopolysaccharide-binding protein precursor | 10.1 | 53,968 | 1 |
Orthologous conversion was necessary to translate rabbit proteins into human proteins. This introduced a set of well-known limitations. The orthologous conversion scheme was as shown in Figure 2. For the orthologous conversion, we attempted a blast similarity operation that translated rabbit proteins in Table 1 into human proteins. The corresponding human proteins are listed in Table 2. Further data on the BHD are provided in the Supplementary Information on the JAMS web server.

Figure 2.
Protein conversion using the blast similarity operation. The process consisted of three steps: (1) obtaining the amino acid sequence of a given rabbit protein; (2) running the blast similarity operation; and (3) selecting the corresponding human protein that exhibited the lowest E-value. For the blast similarity operation, the human ‘RefSeq protein’ was used as the database for blast searching and ‘BLASTP’ was applied to compare protein sequences. The protein with the lowest E-value was selected as the best match. If two or more proteins with the same lowest E-value were identified, the upper listed protein was arbitrarily chosen.
Table 2. Full conversion list from Bonghan liquid proteins of rabbit onto correspondent human proteins
| Rabbit | Human | Similarities | |||
|---|---|---|---|---|---|
| Accession | Name | Accession | Name | E-value | Positives |
| 44889024 | Serum albumin precursor | 4502027 | Albumin precursor | 0 | 536/608 (88%) |
| 6175087 | Serotransferrin precursor | 4557871 | Transferrin | 0 | 597/678 (88%) |
| 112876 | Alpha-1-antiproteinase F precursor | 50363219 | Serine (or cysteine) proteinase inhibitor, clade A | e-147 | 314/388 (80%) |
| 122676 | Hemoglobin subunit beta-1/2 | 4504349 | Beta globin | 2.00E-74 | 140/147 (95%) |
| 125307 | Creatine kinase M-type | 21536288 | Muscle creatine kinase | 0 | 364/381 (95%) |
| 113996 | Apolipoprotein A-I precursor | 4557321 | Apolipoprotein A-I preproprotein | e-113 | 226/253 (89%) |
| 2494026 | Histidine-rich glycoprotein precursor | 4504489 | Histidine-rich glycoprotein precursor | e-117 | 248/338 (73%) |
| 122475 | Hemoglobin subunit alpha-1/2 | 4504345 | Alpha 2 globin | 9.00E-67 | 129/142 (90%) |
| 12644357 | Alpha-2-HS-glycoprotein precursor | 156523970 | Alpha-2-HS-glycoprotein | e-105 | 230/346 (66%) |
| 136066 | Triosephosphate isomerase (TIM) | 4507645 | Triosephosphate isomerase 1 | e-140 | 247/248 (99%) |
| 6093713 | Glycogen phosphorylase, muscle form | 5032009 | Glycogen phosphorylase | 0 | 816/842 (96%) |
| 136466 | Transthyretin (prealbumin) | 4507725 | Transthyretin | 1.00E-61 | 123/127 (96%) |
| 113608 | Fructose-bisphosphate aldolase A | 34577110 | Aldolase A | 0 | 345/364 (94%) |
| 2851533 | Pyruvate kinase isozymes M1/M2 | 33286422 | Pyruvate kinase 3 isoform 2 | 0 | 524/531 (98%) |
| 121088 | Ig gamma chain C region | 33438594 | Major histocompatibility complex, class II, DQ beta 2 | 4.00E-08 | 69/149 (46%) |
| 1722804 | Vitamin D-binding protein precursor | 32483410 | Vitamin D-binding protein precursor | 0 | 430/473 (90%) |
| 20141354 | Beta-enolase | 153267427 | Enolase 3 | 0 | 418/434 (96%) |
| 116596 | Complement C3 alpha chain | 115298678 | Omplement component 3 precursor | 0 | 645/726 (88%) |
| 62287932 | Actin, alpha skeletal muscle | 4501881 | Alpha 1 actin precursor | 0 | 377/377 (100%) |
| 1169794 | Glyceraldehyde-3-phosphate dehydrogenase | 7669492 | Glyceraldehyde-3-phosphate dehydrogenase | 0 | 321/332 (96%) |
| 130488651 | Serpin peptidase inhibitor, clade F | 115583663 | Alpha-2-plasmin inhibitor | 0 | 355/476 (74%) |
| 130498817 | Inter-α-trypsin inhibitor heavy chain2 | 70778918 | Inter-alpha globulin inhibitor H2 polypeptide | 0 | 849/946 (89%) |
| 139654 | Vitronectin precursor | 88853069 | Vitronectin precursor | 0 | 368/483 (76%) |
| 126050 | L-lactate dehydrogenase A chain | 5031857 | Lactate dehydrogenase A | e-173 | 314/332 (94%) |
| 125138 | Ig kappa-b4 chain C region | 13399298 | Immunoglobulin lambda-like polypeptide 1 isoform a precursor | 1.00E-11 | 56/100 (56%) |
| 229506 | 750308A aldolase C | 34577110 | Aldolase A | 0 | 334/363 (92%) |
| 21542114 | Lumican | 4505047 | Lumican precursor | e-102 | 190/192 (98%) |
| 122766 | Hemoglobin subunit gamma | 4885393 | Epsilon globin | 1.00E-68 | 136/147 (92%) |
| 89242507 | Ig gamma1 constant region | 13399298 | Immunoglobulin lambda-like polypeptide 1 isoform a precursor | 3.00E-08 | 56/121 (46%) |
| 1708184 | Hemopexin precursor | 11321561 | Hemopexin | 0 | 401/464 (86%) |
| 118600944 | Parvalbumin alpha | 4506335 | Parvalbumin | 8.00E-42 | 92/110 (83%) |
| 126723362 | ATS-22 | 50363219 | Serine (or cysteine) proteinase inhibitor, clade A | e-146 | 311/388 (80%) |
| 51703336 | Ubiquitin | 113423966 | PREDICTED: similar to Ubiquitin-63E CG11624-PA, | 1.00E-37 | 76/76 (100%) |
| 552374 | Alpha-globin protein | 4504345 | Alpha 2 globin | 1.00E-07 | 24/25 (96%) |
| 130676 | Serum paraoxonase/arylesterase 1 | 19923106 | Paraoxonase 1 | e-176 | 322/355 (90%) |
| 109259 | Ig alpha chain C region (fragment) | 94538335 | Signal-regulatory protein gamma isoform 1 precursor | 3.00E-09 | 74/185 (40%) |
| 2851405 | Myosin light chain kinase, smooth muscle | 116008188 | Myosin light chain kinase isoform 2 | 0 | 810/923 (87%) |
| 1710096 | Plasma retinol-binding protein precursor | 55743122 | Retinol-binding protein 4, plasma precursor | e-103 | 181/188 (96%) |
| 549158 | UDP-glucuronosyltransferase 2B13 precursor | 4507821 | UDP glucuronosyltransferase 2 family, polypeptide B17 | 0 | 426/507 (84%) |
| 20178272 | Tropomyosin beta chain | 42476296 | Tropomyosin 2 (beta) isoform 1 | 2.00E-96 | 200/284 (70%) |
| 126722957 | Alpha-1-antiproteinase S-1 precursor | 50363219 | Serine (or cysteine) proteinase inhibitor, clade A | e-146 | 311/388 (80%) |
| 130483559 | Farnesoid X activated receptor | 4826980 | Nuclear receptor subfamily 1, group H, member 4 | 0 | 435/446 (97%) |
| 30315907 | Eukaryotic translation initiation factor 4 gamma 2 | 4503539 | Eukaryotic translation initiation factor 4 gamma | 0 | 760/889 (85%) |
| 9910666 | Clusterin precursor (Apolipoprotein J) | 42716297 | Clusterin isoform 1 | 0 | 389/448 (86%) |
| 130502756 | Ryanodine receptor | 126032338 | Ryanodine receptor 3 | 0 | 4500/4874 (92%) |
| 125295 | Creatine kinase B-type | 21536286 | Brain creatine kinase | 0 | 361/381 (94%) |
| 3789966 | Fibrinogen A-alpha chain | 11761629 | Fibrinogen, alpha polypeptide isoform alpha preproprotein | 2.00E-96 | 251/446 (56%) |
| 125128 | 6-phosphofructokinase, muscle type | 4505749 | Phosphofructokinase, muscle | 0 | 758/780 (97%) |
| 126723185 | Soluble adenylyl cyclase | 8923844 | Soluble adenylyl cyclase | 0 | 1405/1610 (87%) |
| 127805 | Sodium/glucose cotransporter 1 | 4507031 | Solute carrier family 5 (sodium/glucose cotransporter) | 0 | 555/647 (85%) |
| 1703316 | Annexin A1 (Annexin I) (Lipocortin I) | 4502101 | Annexin I | e-180 | 331/346 (95%) |
| 126722591 | Caldesmon 1 | 15149463 | Caldesmon 1 isoform 4 | 3.00E-84 | 160/174 (91%) |
| 30315951 | Probable phospholipid-transporting ATPase IF Hensin | 62632750 | ATPase, class VI, type 11B | 0 | 1108/1169 (94%) |
| 75052894 | LIM and SH3 domain protein 1 | 5453710 | LIM and SH3 protein 1 | e-131 | 230/264 (87%) |
| 1168847 | T-cell surface glycoprotein CD4 precursor | 10835167 | CD4 antigen precursor | e-136 | 328/460 (71%) |
| 26006805 | Potassium voltage-gated channel subfamily H | 4557729 | Voltage-gated potassium channel, subfamily H | 0 | 974/1161 (83%) |
| 126723568 | ACAP2 protein | 40254842 | Centaurin, beta 2 | 0 | 742/778 (95%) |
| 547983 | Myosin heavy chain, embryonic smooth muscle isoform | 41406064 | Myosin, heavy polypeptide 10, non-muscle | 0 | 397/500 (79%) |
| 47605964 | Rho-associated protein kinase 1 | 4885583 | Rho-associated, coiled-coil containing protein kinase 1 | 0 | 1282/1354 (94%) |
| 232178 | Serine hydroxymethyltransferase, cytosolic | 22547186 | Serine hydroxymethyltransferase 1 (soluble) isoform 1 | 0 | 453/484 (93%) |
| 1384097 | Macrophage migration inhibitory factor-related protein-8 | 21614544 | S100 calcium-binding protein A8 | 1.00E-24 | 61/74 (82%) |
| 55976305 | Sodium channel protein type 9 subunit alpha | 4506813 | Sodium channel, voltage-gated, type IX, alpha | 0 | 1636/1961 (83%) |
| 17366976 | Glucose-6-phosphate isomerase (GPI) | 18201905 | Glucose phosphate isomerase | 0 | 543/558 (97%) |
| 50402101 | Eukaryotic peptide chain release factor subunit 1 | 4759034 | Eukaryotic translation termination factor 1 | 0 | 437/437 (100%) |
| 115055 | Bleomycin hydrolase (BLM hydrolase) | 4557367 | Bleomycin hydrolase | e-158 | 270/277 (97%) |
| 27373403 | Antibody variable domain | 89062025 | PREDICTED: similar to immunoglobulin iota chain | 0.002 | 43/103 (41%) |
| 123255522 | BetaB2-crystallin | 4503063 | Crystallin, beta B2 | e-108 | 186/205 (90%) |
| 125987 | Lipopolysaccharide-binding protein precursor | 31652249 | Lipopolysaccharide-binding protein precursor | e-162 | 350/451 (77%) |
After the conversion, the corresponding human proteins were clustered according to their involvement with biological processes, molecular functions and cellular compartmentalization in GO using DAVID and Cytoscape (Figure 3). In the cases of biological processes, the categories of ‘localization,’ ‘response to stimuli’ and ‘metabolism’ accounted for the majority of the proteins.

Figure 3.
Clustering of proteins identified in Bonghan liquid. The clustering was executed consistent with the three GO domains of biological processes (A), molecular functions (B) and cellular compartmentalization (C). The pie chart values indicate the numbers of proteins included in each category. Certain proteins belonged to more than two categories and as a result the total number of proteins in the pie chart is different from the number of proteins identified in Table 1.
‘Localization’ refers to any process by which a cell or a cellular entity, such as a protein complex or organelle, is transported to and/or maintained in a specific location. Proteins in this category included annexin AI, ATPase class VI, caldesmon, vitamin D binding protein, hemoglobin, hemopexin, transferrin and more. ‘Response to stimulus’ refers to a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression etc.) that occurs as a result of exposure to a stimulus. The ‘Response to stimulus’ category included albumin, annexin AI, bleomycin hydrase, clusterin, crystalline and others. Some proteins, such as annexin AI, belong to two classes. We note that many proteins were related to metabolic processes such as carbohydrate, alcohol and other cellular catabolism.
In the context of molecular function, ‘binding’ and ‘transporter activity’ accounted for almost all of the BHL proteins. With respect to the cellular compartmentalization category, ‘extracellular region’ and ‘protein complex’ were dominant and this could be evidence that our analyses were appropriate. In Table 3, GO clustering of human BHL proteins are presented in terms of biological processes, molecular function and cellular compartmentalization.
Table 3. List of gene ontology clustering of Bonghan liquid proteins in terms of biological process, molecular function and cellular compartment
| GO | ||||
|---|---|---|---|---|
| Accession | Name | Biological process | Molecular function | Cellular component |
| 4502027 | Albumin precursor | Localization, response to stimulus | Binding | Extracellular region, protein complex |
| 4557871 | Transferrin | Localization | Binding | Extracellular region |
| 50363219 | Serine (or cysteine) proteinase inhibitor, clade A | Response to stimulus | Extracellular region | |
| 4504349 | Beta globin | Localization, cellular biosynthetic process, circulation | Binding, transporter activity | Protein complex, cytosol |
| 21536288 | Muscle creatine kinase | Cellular biosynthetic process | Phosphotransferase activity, nitrogenous group as acceptor | |
| 4557321 | Apolipoprotein A-I preproprotein | Localization, alcohol metabolic process, circulation | Transporter activity | Extracellular region |
| 4504489 | Histidine-rich glycoprotein precursor | Extracellular region | ||
| 4504345 | Alpha 2 globin | Localization | Binding, transporter activity intramolecular oxidoreductase activity, interconverting aldoses and ketoses | Protein complex, cytosol |
| 4507645 | Triosephosphate isomerase 1 | Cellular carbohydrate metabolic process, cellular catabolic process, alcohol metabolic process, cellular biosynthetic process | ||
| 5032009 | Glycogen phosphorylase | Cellular carbohydrate metabolic process, cellular catabolic process | Binding | |
| 4507725 | Transthyretin | Localization | Binding, transporter activity | Extracellular region |
| 34577110 | Aldolase A | Cellular carbohydrate metabolic process, cellular catabolic process, alcohol metabolic process, muscle contraction | ||
| 33286422 | Pyruvate kinase 3 isoform 2 | Cellular carbohydrate metabolic process, cellular catabolic process, alcohol metabolic process | Binding | Cytosol |
| 33438594 | Major histocompatibility complex, class II, DQ beta 2 | Response to stimulus | MHC class II receptor activity | Protein complex |
| 32483410 | Vitamin D-binding protein precursor | Localization | Binding, transporter activity | Extracellular region |
| 4501881 | Alpha 1 actin precursor | Muscle contraction | Binding | Striated muscle thin filament, stress fiber |
| 7669492 | Glyceraldehyde-3-phosphate dehydrogenase | Cellular carbohydrate metabolic process, cellular catabolic process, alcohol metabolic process | Binding | |
| 70778918 | Inter-alpha globulin inhibitor H2 polypeptide | Cellular carbohydrate metabolic process | Extracellular region | |
| 88853069 | Vitronectin precursor | Response to stimulus | Extracellular region | |
| 5031857 | Lactate dehydrogenase A | Cellular carbohydrate metabolic process, cellular catabolic process, alcohol metabolic process | Cytosol | |
| 13399298 | Immunoglobulin lambda-like polypeptide 1 isoform a precursor | Response to stimulus | ||
| 34577110 | Aldolase A | Cellular carbohydrate metabolic process, cellular catabolic process, alcohol metabolic process, muscle contraction | ||
| 4505047 | Lumican precursor | Extracellular region | ||
| 4885393 | Epsilon globin | Localization | Binding, transporter activity | Protein complex, cytosol |
| 13399298 | Immunoglobulin lambda-like polypeptide 1 isoform a precursor | Response to stimulus | ||
| 11321561 | Hemopexin | Localization | Binding, transporter activity | Extracellular region |
| 50363219 | Serine (or cysteine) proteinase inhibitor, clade A | Response to stimulus | Extracellular region | |
| 4504345 | Alpha 2 globin | Localization | Binding, transporter activity | Protein complex, cytosol |
| 19923106 | Paraoxonase 1 | Response to stimulus | Transporter activity | Extracellular region |
| 55743122 | Retinol-binding protein 4, plasma precursor | Localization, response to stimulus | Binding, transporter activity | Extracellular region |
| 42476296 | Tropomyosin 2 (beta) isoform 1 | Binding | Striated muscle thin filament | |
| 50363219 | Serine (or cysteine) proteinase inhibitor, clade A | Response to stimulus | Extracellular region | |
| 4503539 | Eukaryotic translation initiation factor 4 gamma, 2 isoform 1 | Cellular biosynthetic process | Protein complex | |
| 42716297 | Clusterin isoform 1 | Response to stimulus | Extracellular region | |
| 21536286 | Brain creatine kinase | Phosphotransferase activity, nitrogenous group as acceptor | ||
| 11761629 | Fibrinogen, alpha polypeptide isoform alpha preproprotein | Response to stimulus, circulation | Binding | Extracellular region, protein complex |
| 4505749 | Phosphofructokinase, muscle | Cellular carbohydrate metabolic process, cellular catabolic process, alcohol metabolic process | Protein complex, cytosol | |
| 8923844 | Soluble adenylyl cyclase | Cellular biosynthetic process | Cytosol | |
| 4507031 | Solute carrier family 5 (sodium/glucose cotransporter), member 1 | Localization | Binding, transporter activity | |
| 4502101 | Annexin I | Localization, response to stimulus | Binding | |
| 15149463 | Caldesmon 1 isoform 4 | Localization, muscle contraction | Binding | |
| 62632750 | ATPase, class VI, type 11B | Localization | Transporter activity | |
| 5453710 | LIM and SH3 protein 1 | Localization | Binding, transporter activity | |
| 10835167 | CD4 antigen precursor | Response to stimulus, cellular biosynthetic process | Protein complex | |
| 4557729 | Voltage-gated potassium channel, subfamily H, member 2 isoform a precursor | Localization, circulation, muscle contraction | Binding, transporter activity, phosphotransferase activity, nitrogenous group as acceptor | Protein complex |
| 41406064 | Myosin, heavy polypeptide 10, non-muscle | Binding | Protein complex, stress fiber | |
| 22547186 | Serine hydroxymethyltransferase 1 (soluble) isoform 1 | Cellular catabolic process | Binding | Cytosol |
| 21614544 | S100 calcium-binding protein A8 | Response to stimulus | Extracellular region | |
| 4506813 | Sodium channel, voltage-gated, type IX, alpha | Localization | Binding, transporter activity | Protein complex |
| 18201905 | Glucose phosphate isomerase | Response to stimulus, cellular carbohydrate metabolic process, cellular catabolic process, alcohol metabolic process, cellular biosynthetic process | Intramolecular oxidoreductase activity, interconverting aldoses and ketoses | Extracellular region |
| 4759034 | Eukaryotic translation termination factor 1 | Cellular biosynthetic process | ||
| 4557367 | Bleomycin hydrolase | Response to stimulus | Bleomycin hydrolase activity | |
| 4503063 | Crystallin, beta B2 | Response to stimulus | ||
| 31652249 | Lipopolysaccharide-binding protein precursor | Localization, response to stimulus | Extracellular region | |
3.2. Proteomic analysis of BHD
We also performed proteomic analyses of the BHD. The number of proteins identified in BHD was 207 (Table 4). The rabbit proteins identified in the BHD and their corresponding human proteins are shown in Table 5. GO clustering of the BHD proteins in Table 6 was achieved as in the case of BHL (Figure 4). Tables 4–6 are Supplementary Information.

Figure 4.
Clustering of proteins identified in Bonghan duct. Note the similarity with Figure 3.
For biological processes, we identified several categories: (1) ‘metabolic process’ (annexin Al, ATP synthase-H+ transporting, ATPase-Na+/K+ transporting, carbonic anhydrase II, cytochrome b5 type A, fructose-1, 6-bisphosphatasae, lactate dehydrogenase A, etc.), (2) ‘localization’ (annexin Al, calreticulin, cytochrome b5 type A, vitamin D binding protein, hemoglobin, hemopexin, transferrin, vimentin, etc.), (3) ‘response to stimulus’ (albumin, aldo-keto reductase family 1, annexin Al, annexin All, arginase type II, clusterin, glucose phosphate isomerase, isocitrate dehydrogenase 1, protein phosphatase 2, etc.), and (4) ‘cell development’ (actin alpha1, actin beta, albumin, annexin Al, apolipoprotein E, calreticulin, clusterin, protein disulfide isomerase family A, protein kinase C, protein phosphatase 2, etc.).
With regard to molecular function, ‘binding,’ ‘catalytic activity’ and ‘transporter activity’ were prominent. In the case of cellular compartmentalization, the ‘intracellular part’ was dominant and other categories such as ‘extracellular region,’ ‘macromolecular complex’ and ‘cell fraction’ were also evidenced. The GO clustering of human BHD proteins is shown in Table 6, categorized again in terms of biological processes, molecular functions and cellular compartmentalization.
4. Discussion
Our study used proteomics to conduct molecular investigations into the BHD. The rabbit was selected to achieve our minimum required sample volume, but the database for functional clustering of proteins was incomplete. Therefore, the rabbit proteins identified in BHL and the BHD had to be associated with corresponding human proteins. A blast similarity operation was used to achieve this association. This operation uses a search strategy to match a given rabbit protein with the exact or closest amino acid sequence in a human protein database, as described in Figure 2. We note that this process is limited because of the possibility of protein conversions that do not maintain cross-species functionality. However, orthologous conversions have been successfully used in other cases where species-specific protein databases were unavailable [29]. In this study, almost all the corresponding human proteins were identical or similar to the original rabbit proteins when we conducted a manual survey of their functionalities.
The human proteins used in the blast similarity search were clustered into three domains, namely, biological processes, molecular functions and cellular compartmentalization. In this search we used Cytoscape, a free software program (www.cyto-scape.org). In the “biological processes” category, it was clear that metabolic processes, especially carbohydrate-based ones, were very prominent categories in both BHL and the BHD. Other scientists have reported proteomic analyses of blood and lymph that do not show these remarkable carbohydrate-based processes [18, 19]. Another study concluded that the proteome of blood vessels also included few carbohydrate-based processes [20]. Our findings imply that either BHL or the BHD must require an efficient energy supply. Proteomic analyses of certain cell types such as stem cells, cancer cells and differentiated myeloid cells, all of which show vigorous proliferation or differentiation, have shown a similar abundance of carbohydrate- or energy-related processes [21, 22, 23, 24].
We note the existence of proteins related to (1) the recruitment of mesenchymal stem cells (MSC) [25], (2) the cell processes in MSCs (Ezrin, Actinin, myosin) [26], and (3) the differentiation of MSC/myofibroblasts (alpha-smooth muscle actin, CD147) [27]. These protein profiles suggest that BHDs located on the organ surface has a role as a temporary depot and point of differentiation of stem cells for tissue regeneration.
In conclusion, our proteomic analysis of rabbit BHL and BHDs suggests that proteins can be categorized in terms of their involvement with biological processes, molecular functions and cellular compartmentalization following orthologous conversion to human proteins. The abundance of carbohydrate-based processes was surprising. This fact distinguished the proteomic fingerprint of the Bonghan system from that of blood, lymph or blood vessel physiology, but was similar to that of stem cells, especially mesenchymal stem cells, cancer cells and differentiated myeloid cells.
Acknowledgments
This research was supported by a NRL (No.R0A-2003-000-10371-0) from the Korean Ministry of Education, Science and Technology and by a “Systems Biology Infrastructure Establishment Grant” from the Gwangju Institute of Science and Technology.
Tables of Data
Database analysis
All MS/MS spectra recorded were searched on rabbit database, obtained from the taxonomy site in NCBI (www.ncbi.nlm.nih.gov/sites/entrez?db=taxonomy), by using the SEQUEST algorithm. Dynamic modifications were permitted for oxidized methio-nine (+16Da), carboxyamidomethylated cysteine (+57Da). SEQUEST criteria for peptide selection were Xcorr, which must be greater than 1.8, 2.3 and 3.5 for +1, +2 and +3 charge state respectively, and delta Cn above 0.1. The parameter for selection of identified proteins was a protein consensus score which was above 10.1. Due to the poorness of the functional DB for rabbits, it was needed to orthologously convert the rabbit proteins into corresponding human proteins. Blast similarity operation, provided by NCBI, was used for this purpose. The resulting human proteins were clustered according to biological process, molecular function and cellular compartment with the help of Cytoscape (www.cytoscape.org) which was freely obtained from the web.
Table 1 List of proteins identified in Bonghan liquid. The accession column refers to GI accession number, the score refers to the consensus score from SEQUEST, MW is molecular weight and peptide is the number of peptides identified by proteomic analysis. The × correlation value (greater than 1.8, 2.3 and 3.5 for +1, +2 and +3 charges, respectively), delta Cn (greater than 0.1), and number of top matches (only 1) were used as criteria for peptide selection. The consensus score was utilized for filtering proteins. Proteomic analysis of Bonghan liquid was conducted twice and this table shows results from just one experiment. Only part of the protein conversion results are listed in this table. The total protein conversion list is shown in Table 2, in the supplementary material.
Table 2 Conversion of Bonghan liquid proteins from rabbit into corresponding human proteins. E-value is a parameter that describes the number of hits one can “expect” to see by chance when searching a database of a particular size. The lower E-value indicates the more valid result. ‘Positive’ means positive matrix score which is expressed as the ratio of the number of identified or conserved amino acids to the total number of amino acids of each protein. In the process of protein conversion, one protein from rabbits (part of fibrinogen alpha chain; GI number, 120095) was missed because the short peptide consists of only 16 amino acids.
References
- . On the Kyungrak system . J Acad Med Sci DPR Korea . 1963;90:1–35
- . The Sanal Theory . J Acad Med Sci DPR Korea . 1965;108:39–62
- . ‘Bonghan theory’ morphological studies . Iagku no Ayumi . 1967;60:567–577
- . Tubular structure of intravascular thread-like structures from rats and rabbits . J Korean Physical Soc . 2004;44:1602–1604
- Acridine orange staining method to reveal the characteristic features of an intravascular threadlike structure . Anat Rec B New Anat . 2004;278:27–30
- Acupuncture meridian and intravascular Bonghan duct . Key Engineering Materials . 2005;277:125–129
- . Novel threadlike structures (Bonghan ducts) inside lymphatic vessels of rabbits visualized with a Janus Green B staining method . The Anatomical Record (Part B: New Anat.) . 2005;286B:1–7
- Use of magnetic nanoparticles to visualize threadlike structures inside lymphatic vessels of rats . Evid Based Complement Alternat Med . 2007;4:77–82
- In vivo fluorescence imaging of threadlike tissues (Bonghan ducts) inside lymphatic vessels with nanoparticles . Curr Appl Phys . 2007;4:342–348
- . Unique Duct system and the corpuscle-like structures found on the surface of the liver . J Int Soc Life Inform Science . 2004;22:460–462
- . Bonghan ducts on the surface of rat internal organs . J Int Soc Life Inform Science . 2004;22:455–459
- Feulgen reaction study of novel threadlike structures (Bonghan ducts) on the surface of mammalian organs . The Anatomical Record (Part B: New Anat.) . 2005;284B:35–40
- Electron microscopic study of novel threadlike structures on the surfaces of mammalian organs . Microsc Res Tech . 2007;70:34–43
- . Alcian blue staining method to visualize bonghan threads inside large caliber lymphatic vessels and x-ray microtomography to reveal their microchannels . Lymphat Res Biol . 2006;4:181–190
- . Immuno-histochemical characterization of intravascular Bonghan duct . Microcirculation . 2006;13:166
- Measurement of flow speed in the channels of novel threadlike structures on the surfaces of mammalian organs . Naturwissenschaften . 2008;95:117–124
- Cate-cholamine producing novel endocrine organ: Bonghan system . Med Acupunct . 2008;20:97–102
- Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry . Mol Cell Proteomics . 2002;1:947–955
- Proteomic analysis of lymph . Proteomics . 2004;4:753–765
- . Identification of the surface-accessible, lineage-specific vascular proteome by two-dimensional peptide mapping . FASEB J . 2008;22:1933–1944
- . Two-dimensional gel electrophoresis database of murine R1 embryonic stem cells . Proteomics . 2004;4:3813–3832
- . Proteomic signature of human embryonic stem cells . Proteomics . 2006;6:3544–3549
- Adaptation of energy metabolism in breast cancer brain metastases . Cancer Res . 2007;67:1472–1486
- Genomic and proteomic analysis of the myeloid differentiation program: global analysis of gene expression during induced differentiation in the MPRO cell line . Blood . 2002;100:3209–3220
- Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation . Stem Cells . 2006;24:23–33
- Processus and recessus adhaerentes: giant adherens cell junction systems connect and attract human mesenchymal stem cells . Cell Tissue Res . 2007;328:499–514
- Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling . FASEB J . 2008;22:1144–1154
- Comparative analysis of cell surface proteins in chronic and acute leukemia cell lines . Biochem Biophys Res Commun . 2007;357:620–626
- . Comprehensive analysis of orthologous protein domains using the HOPS database . Genome Res . 2003;13:2353–2362
PII: S2005-2901(09)60029-7
doi:10.1016/S2005-2901(09)60029-7
© 2008 Korean Pharmacopuncture Institute. Published by Elsevier Inc. All rights reserved.
Volume 1, Issue 2 , Pages 97-109, December 2008
